Sabry Shaarawy

590 total citations
22 papers, 477 citations indexed

About

Sabry Shaarawy is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sabry Shaarawy has authored 22 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Sabry Shaarawy's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer Risks and Factors (2 papers). Sabry Shaarawy is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer Risks and Factors (2 papers). Sabry Shaarawy collaborates with scholars based in Egypt, India and United States. Sabry Shaarawy's co-authors include Abdel‐Rahman N. Zekri, Mona S. Abdellateif, Abeer A. Bahnassy, Zakaria Y. Abd Elmageed, Emad Kandil, Amany A. Tohamy, Khalid Matrougui, Ahmed El Bastawisy, Marwa Mohanad and Manal F. Ismail and has published in prestigious journals such as Scientific Reports, Life Sciences and Pharmacological Research.

In The Last Decade

Sabry Shaarawy

21 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabry Shaarawy Egypt 11 146 125 80 74 74 22 477
Bhagyalakshmi Nair India 14 183 1.3× 109 0.9× 87 1.1× 42 0.6× 54 0.7× 36 511
Hongsheng Lin China 13 337 2.3× 147 1.2× 53 0.7× 64 0.9× 112 1.5× 26 697
Qingling Li China 11 186 1.3× 77 0.6× 47 0.6× 24 0.3× 58 0.8× 40 515
Nannan Liu China 15 267 1.8× 64 0.5× 162 2.0× 33 0.4× 37 0.5× 48 656
Yashang Lee United States 14 429 2.9× 102 0.8× 53 0.7× 84 1.1× 58 0.8× 18 888
Rebeca García‐Román Mexico 11 159 1.1× 39 0.3× 107 1.3× 36 0.5× 57 0.8× 19 395
Wenguang Fu China 16 251 1.7× 128 1.0× 188 2.4× 80 1.1× 68 0.9× 60 693
Tae Won Choi South Korea 13 202 1.4× 144 1.2× 104 1.3× 31 0.4× 35 0.5× 27 590
Marie Yeo South Korea 19 376 2.6× 153 1.2× 78 1.0× 64 0.9× 70 0.9× 27 892

Countries citing papers authored by Sabry Shaarawy

Since Specialization
Citations

This map shows the geographic impact of Sabry Shaarawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabry Shaarawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabry Shaarawy more than expected).

Fields of papers citing papers by Sabry Shaarawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabry Shaarawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabry Shaarawy. The network helps show where Sabry Shaarawy may publish in the future.

Co-authorship network of co-authors of Sabry Shaarawy

This figure shows the co-authorship network connecting the top 25 collaborators of Sabry Shaarawy. A scholar is included among the top collaborators of Sabry Shaarawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabry Shaarawy. Sabry Shaarawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohanad, Marwa, Abeer A. Bahnassy, Sabry Shaarawy, et al.. (2025). Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer. Scientific Reports. 15(1). 6894–6894. 1 indexed citations
2.
Roshdy, Wael H., et al.. (2023). ASSESSMENT OF THE IMPACT OF THE EGYVIR ON RATS EXPERIMENTAL ANIMALS; A PRECLINICAL STUDY FOR SARS-COV-2 TREATMENT. Journal of Microbiology Biotechnology and Food Sciences. e9658–e9658.
3.
Gaafar, Rabab, Sabry Shaarawy, Mona S. Abdellateif, et al.. (2022). Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients. Journal of the Egyptian National Cancer Institute. 34(1). 31–31. 5 indexed citations
4.
Shaarawy, Sabry, et al.. (2021). The Role of Different Inflammatory Indices in the Diagnosis of COVID-19. International Journal of General Medicine. Volume 14. 7843–7853. 34 indexed citations
5.
Abdellateif, Mona S., et al.. (2020). The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. Journal of Inflammation Research. Volume 13. 1245–1259. 10 indexed citations
6.
Ashmawy, Abeer M., et al.. (2020). Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines. Asian Pacific Journal of Cancer Prevention. 21(8). 2243–2250. 7 indexed citations
7.
Bastawisy, Ahmed El, Mona S. Abdellateif, Abdel‐Rahman N. Zekri, et al.. (2020). The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt. Diagnostic Pathology. 15(1). 10–10. 9 indexed citations
8.
Shaarawy, Sabry, et al.. (2020). The Role of CYP2D6 Polymorphisms in Determining Response to Tamoxifen in Metastatic Breast Cancer Patients: Review and Egyptian Experience. Asian Pacific Journal of Cancer Prevention. 21(12). 3619–3625. 7 indexed citations
9.
Abdellateif, Mona S., et al.. (2020). The Role of Vitamin D, Platelet-Derived Growth Factor and Insulin-Like Growth Factor 1 in the Progression of Thyroid Diseases. Asian Pacific Journal of Cancer Prevention. 21(7). 2083–2089. 6 indexed citations
10.
Abdellateif, Mona S., et al.. (2020). <p>Obesity and Waist Circumference are Possible Risk Factors for Thyroid Cancer: Correlation with Different Ultrasonography Criteria</p>. Cancer Management and Research. Volume 12. 6077–6089. 6 indexed citations
11.
12.
13.
Bahnassy, Abeer A., Marwa Mohanad, Manal F. Ismail, et al.. (2015). Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt. Experimental and Molecular Pathology. 99(2). 303–311. 25 indexed citations
14.
Azab, Samar S., et al.. (2013). Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sciences. 92(10). 555–561. 30 indexed citations
15.
Ashmawy, Abeer M., et al.. (2011). siRNA Mediated-hTERT Knockdown Impedes Proliferation of Mammalian Cancer MCF7 and HepG2 Cells. 7(3). 1 indexed citations
16.
Shaarawy, Sabry, et al.. (2010). Prognostic Value of Membrane Type 1 and 2 Matrix Metalloproteinase Expression and Gelatinase a Activity in Bladder Cancer. The International Journal of Biological Markers. 25(2). 69–74. 18 indexed citations
17.
Shaarawy, Sabry, et al.. (2009). Protective Effects of Garlic and Silymarin on NDEA-Induced Rats Hepatotoxicity. International Journal of Biological Sciences. 5(6). 549–557. 124 indexed citations
18.
Zekri, Abdel‐Rahman N., et al.. (2008). Expression of pro‐ and anti‐inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV‐genotype‐4. Journal of Gastroenterology and Hepatology. 24(3). 416–428. 24 indexed citations
19.
Zekri, Abdel‐Rahman N., et al.. (2000). Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. Journal of Medical Microbiology. 49(1). 89–95. 44 indexed citations
20.
Sayed‐Ahmed, Mohamed M., Sabry Shaarawy, Samia A. Shouman, & Abdel‐Moneim M. Osman. (1999). REVERSAL OF DOXORUBICIN-INDUCED CARDIAC METABOLIC DAMAGE BYL-CARNITINE. Pharmacological Research. 39(4). 289–295. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhagyalakshmi Nair Breakdown of academic impact, for papers by Hongsheng Lin Breakdown of academic impact, for papers by Qingling Li Breakdown of academic impact, for papers by Nannan Liu Breakdown of academic impact, for papers by Yashang Lee Breakdown of academic impact, for papers by Rebeca García‐Román Breakdown of academic impact, for papers by Wenguang Fu Breakdown of academic impact, for papers by Tae Won Choi Breakdown of academic impact, for papers by Marie Yeo
Rankless by CCL
2026